Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:BDRX 10 December 2025

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) closed at $4.09 on December 9, down 53.5% from the prior session, after wild swings that saw the stock trade between $4.00 and $7.60 intraday. The company is advancing a Phase 3 trial in a rare inherited cancer syndrome and exploring new financing. Its float remains under 670,000 ADSs, fueling extreme volatility. Market cap stands near $5.5 million.
10 December 2025
··
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

A SPAC III Acquisition (ASPC) surged over 100% pre-market Dec. 10, trading between $25 and $31 after sharp gains in after-hours. Enveric Biosciences (ENVB) and Biodexa Pharmaceuticals (BDRX) also posted triple- and double-digit percentage gains. Major U.S. index futures were little changed ahead of the Federal Reserve’s final 2025 rate decision. Speculative micro-caps and SPACs led early trading volatility.
10 December 2025
··········
Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy

Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy

A SPAC III Acquisition Corp. surged over 219% pre-market Wednesday, leading U.S. gainers as traders await the Federal Reserve’s final 2025 policy decision. Nasdaq 100, S&P 500, and Dow futures ticked higher, while the 10-year Treasury yield hovered near 4.18%. Silver traded above $61 an ounce. Other top pre-market movers included Enveric Biosciences, Biodexa Pharmaceuticals, and Ashford Hospitality Trust.
10 December 2025
··········

Stock Market Today

  • Russell 2000 Hits Correction Territory Amid Oil Price Surge and Economic Worries
    March 20, 2026, 2:58 PM EDT. The Russell 2000 small-cap index has dropped over 10% from its recent peak, marking the first major U.S. benchmark to enter correction territory, defined as a decline between 10% and 20%. The index, initially outperforming in 2026, fell sharply due to a surge in Brent crude oil prices amid the Iran war, highlighting small caps' sensitivity to cyclical sectors and economic downturns. Other major indexes are close behind, with the Dow and Nasdaq down over 9%, and the S&P 500 falling by more than 6%, signaling broader market pressures.
Go toTop